igf-1 lr3 safety risks side effects IGF1-LR3 Peptide Late-life targeting of the IGF-1

Kim JY, Kanai Y, Chairoungdua A, et al

Take 1 capsule daily with water after meals for best results

Analysis of adverse effects (OR = 0.03, 95% CI: 0.030.09) revealed comparable safety profiles, with reported events primarily consisting of gastrointestinal symptoms (abdominal pain, nausea, reflux, diarrhea, constipation, flatulence, and indigestion), neurological effects (headache and daytime drowsiness), and occasional hypersensitivity reactions or cold sores

But at Perfect B, the patients who start seeing the early signs of GHK-Cu decline are typically in their mid-to-late 20s

Persistent or severe hypoglycemic episodes despite proper meal timing